Hypha Labs Acquires State-of-the-Art HPLC Analytic Machine and Partners with Lucidity Systems for Advanced Autosampler Upgrade | FUNI Stock News

Author's Avatar
May 01, 2025
Article's Main Image
  • Hypha Labs (OTCQB:FUNI) enhances its analytical capabilities with new HPLC machine acquisition.
  • Partnership with Lucidity Systems grants early access to advanced autosampler technology.
  • Technological upgrades improve measurement precision and consistent product outcomes.

Hypha Labs, Inc. (OTCQB:FUNI), a leader in functional mushroom sciences, has made strides in precision measurement and analysis with the acquisition of a cutting-edge High-Performance Liquid Chromatography (HPLC) analytic machine. This new equipment is poised to significantly enhance Hypha Labs' ability to conduct precise measurements of their MicroPearls™ product line, a key offering in their suite of functional mushroom-based products.

In a strategic move to bolster its research and development capabilities, Hypha Labs has also partnered with Lucidity Systems, securing early access to their newly released variable loop autosampler upgrade. This advanced technology is expected to improve peak separation and elevate potency resolution, thereby enabling the company to perform more precise analytical tasks with their Mushroom Accelerator machine.

These advancements are set to provide Hypha Labs with deeper insights into the compounds of their MicroPearl products, ensuring higher accuracy in measuring potency and more effective quality control. The enhancements promise a more consistent outcome for consumers, further positioning Hypha Labs as a key player in the functional mushroom industry.

John Frailey, the Chief Technology Officer at Hypha Labs, expressed enthusiasm about the developments, stating, "We are thrilled to partner with Lucidity Systems and gain early access to their latest ground-breaking technology. This upgrade will not only enhance our analytical capabilities but also empower us to push the boundaries of our research in the field of mycology."

As Hypha Labs continues to innovate within the realm of mushroom-based science and technology, these acquisitions mark a significant milestone in their journey to deliver cutting-edge solutions and research advancements to their customers and partners.

Disclosures

I/We may personally own shares in some of the companies mentioned above. However, those positions are not material to either the company or to my/our portfolios.